Equities

Valeo Pharma Inc

Valeo Pharma Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.065
  • Today's Change0.00 / 0.00%
  • Shares traded8.00k
  • 1 Year change-72.92%
  • Beta2.3814
Data delayed at least 15 minutes, as of Sep 20 2024 20:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in CAD

The one analyst offering a 12 month price target expects Valeo Pharma Inc share price to rise to 0.40 in the next year from the last price of 0.065.
High515.4%0.40
Med515.4%0.40
Low515.4%0.40

Earnings history & estimates in CAD

On Sep 12, 2024, Valeo Pharma Inc reported 3rd quarter 2024 losses of -0.08 per share.
The next earnings announcement is expected on Jan 29, 2025.
Average growth rate-11.34%
Valeo Pharma Inc reported annual 2023 losses of -0.32 per share on Jan 29, 2024.
Average growth rate-30.00%
More ▼

Revenue history & estimates in CAD

Valeo Pharma Inc. had 3rd quarter 2024 revenues of 12.60m. This was 4.26% below the prior year's 3rd quarter results.
Average growth rate-2.52%
Valeo Pharma Inc. had revenues for the full year 2023 of 53.91m. This was 94.31% above the prior year's results.
Average growth rate+93.48%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.